Brighton Jones LLC’s Gossamer Bio GOSS Stock Holding History

Brighton Jones LLC’s Portfolio GOSS Stock Details GOSS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$5.32K	Buy	404 +153	+61%	+$3.42K	﹤0.01%	1419
2026 Q1	$6.59K	Buy	+251	New	+$31.6K	﹤0.01%	1200
2025 Q4	–	Sell	-172	Closed	-$36.2K	–	410
2025 Q3	$36.2K	Buy	+172	New	+$30.3K	﹤0.01%	1011

Other funds holding GOSS

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

6CM

683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return

DIG

DeepCurrents Investment Group New York $3.3B AUM 12.57% 1-Year Est. Return

CCM

Context Capital Management Lajolla, California $5.15B AUM 1.28% 1-Year Est. Return

WVP

Worth Venture Partners Fort Lee, New Jersey $44.3M AUM 34.55% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return

WAM

Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.65% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

KCM

Kalehua Capital Management Dallas, Texas $174M AUM

Brighton Jones LLC's GOSS Position: Q2 2026 in Review

Brighton Jones LLC increased its Gossamer Bio (GOSS) stake by 61% in Q2 2026, buying an estimated $3.42K and bringing the position to 404 shares worth $5.32K. The position accounts for ﹤0.01% of the portfolio, ranked #1419.

Brighton Jones LLC first reported a position in GOSS in Q3 2025 and has held it in 3 quarters since. The position peaked at $36.2K in Q3 2025. 166 funds tracked by Wall St. Rank hold GOSS as of Q2 2026.

Brighton Jones LLC held 404 shares of Gossamer Bio worth $5.32K as of Q2 2026.
Brighton Jones LLC bought 153 Gossamer Bio shares in Q2 2026, an estimated $3.42K.
Gossamer Bio made up ﹤0.01% of Brighton Jones LLC's portfolio in Q2 2026, its #1419 holding.
Brighton Jones LLC first reported a position in Gossamer Bio in Q3 2025 and has held it in 3 quarters since.
Brighton Jones LLC's Gossamer Bio position peaked at $36.2K in Q3 2025.
166 funds tracked by Wall St. Rank held Gossamer Bio as of Q2 2026.

Based on Brighton Jones LLC's 13F filing for Q2 2026, filed 11 Aug 2026.